Clinical predictors of acute response with olanzapine in psychotic mood disorders

Journal of Clinical Psychiatry

Volumn 59, Issue 1, 1998, Pages 24-28

  Zarate Jr , Carlos A ^a   Narendran, Rajesh ^a,b   Toben, Mauricio ^a,c   Greaney, Jim J ^a,d   Berman, Arielle ^b,d   Pike, Stephanie ^c,d   Madrid, Alex ^a,c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

AGITATION; ARTICLE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG INDUCED DISEASE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SEDATION; SEX RATIO; TREATMENT OUTCOME;

EID: 2642671152     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0106     Document Type: Article

References (18)

1. Baldessarini RI, Tondo L, Suppes T, et al. Pharmacological treatment of bipolar disorder across the life cycle. In: Shulman KI, Tohen M, Kutcher SP, eds. Mood Disorders Across the Life Span. New York, NY: John Wiley & Sons; 1996:299-338
2. Keck PE Jr, McElroy SL, Nemeroff CB. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:395-405
3. Tohen M, Zarate CA Jr. Antipsychotic agents and bipolar disorder. J Clin Psychiatry I998;59(suppl l):38-48
4. McElroy SL, Dessain EC, Pope HG Jr, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991:52:411-414
5. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995:56:411-417
6. Calabrese JR, Kimmel SE, Woyshville NU, et al. Clozapine for treatmentrefractory mania. Am J Psychiatry 1996:153:759-764
7. Tohen M, Zarate CA Jr, Centorrino F, et al. Risperidone in the treatment of mania. J Clin Psychiatry 1996;57:249-253
8. Banov MD, Zarate CA Jr, Tohen M, et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994:55:295-300
9. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994; 151:825-835
10. Hillert A, Maier W, Wetzel H, et al. Risperidone in the treatment of affective disorders with a combined psychotic and depressive syndrome: a functional approach. Pharmacopsychiatry 1992;25:2I3-217
11. Dwight MM, Keck PE Jr, Stanton SP, et al. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet l994;344:554-555
12. Suppes T, McElroy S, Gilbert J, et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270-280
13. Zarate CA Jr, Tbhen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry 1995;56:108-112
14. Keck PE Jr, Wilson DR, Strakowski SM, et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995;56:466-470
15. Beasley CM, Tollefson G, Tran P, et al. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine. trial. Neuropsychopharmacology 1996;14:111-123
16. Baker R, Ames D, Umbricht D, et al. Olanzapine's impact on depressive and obsessive-compulsive symptoms in schizophrenia. Psychopharmacol Bull 1995:31:549
17. Tollefson CD, Beasley CM Jr, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997;154:457-465
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994